Orchid Pharma 관리
관리 기준 확인 3/4
We currently do not have sufficient information about the CEO.
주요 정보
Manish Dhanuka
최고 경영자
₹35.5m
총 보상
CEO 급여 비율 | 22.3% |
CEO 임기 | 4.4yrs |
CEO 소유권 | n/a |
경영진 평균 재임 기간 | 4.4yrs |
이사회 평균 재임 기간 | 4.4yrs |
최근 관리 업데이트
Recent updates
Earnings Tell The Story For Orchid Pharma Limited (NSE:ORCHPHARMA) As Its Stock Soars 26%
Jul 29We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | ₹1b |
Mar 31 2024 | ₹36m | ₹8m | ₹922m |
Dec 31 2023 | n/a | n/a | ₹1b |
Sep 30 2023 | n/a | n/a | ₹1b |
Jun 30 2023 | n/a | n/a | ₹775m |
Mar 31 2023 | ₹12m | ₹8m | ₹531m |
Dec 31 2022 | n/a | n/a | -₹175m |
Sep 30 2022 | n/a | n/a | -₹356m |
Jun 30 2022 | n/a | n/a | -₹471m |
Mar 31 2022 | ₹7m | ₹7m | -₹604m |
Dec 31 2021 | n/a | n/a | -₹592m |
Sep 30 2021 | n/a | n/a | -₹934m |
Jun 30 2021 | n/a | n/a | -₹1b |
Mar 31 2021 | ₹5m | ₹5m | -₹952m |
보상 대 시장: Manish's total compensation ($USD422.25K) is about average for companies of similar size in the Indian market ($USD364.25K).
보상과 수익: Manish's compensation has increased by more than 20% in the past year.
CEO
Manish Dhanuka (57 yo)
4.4yrs
테뉴어
₹35,510,053
보상
Shri. Manish Dhanuka serves as Director at Orchid Pharma Limited since March 31, 2020 and serves as its Managing Director since June 29, 2020. He serves as Non-Executive Non-Independent Director since Nove...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
MD & Director | 4.4yrs | ₹35.51m | 데이터 없음 | |
Chief Financial Officer | 4.4yrs | ₹5.48m | 데이터 없음 | |
Company Secretary & Compliance Officer | less than a year | ₹429.00k | 데이터 없음 | |
Whole Time Director | 4.4yrs | ₹35.51m | 데이터 없음 | |
Head of Human Resources | 23.8yrs | 데이터 없음 | 데이터 없음 | |
President of API | no data | ₹6.68m | 데이터 없음 | |
VP and Unit Head of API & FDF | no data | 데이터 없음 | 데이터 없음 | |
Head of CTD & IPM | no data | 데이터 없음 | 데이터 없음 | |
Chief Executive Officer of Orchid AMS | less than a year | 데이터 없음 | 데이터 없음 | |
Head of Medico Marke | less than a year | 데이터 없음 | 데이터 없음 | |
Head of Information Technology | 17.8yrs | 데이터 없음 | 데이터 없음 |
4.4yrs
평균 재임 기간
55.5yo
평균 연령
경험이 풍부한 관리: ORCHPHARMA's management team is considered experienced (4.4 years average tenure).
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
MD & Director | 4.7yrs | ₹35.51m | 데이터 없음 | |
Whole Time Director | 4.7yrs | ₹35.51m | 데이터 없음 | |
Non Executive Chairman | 4.7yrs | 데이터 없음 | 데이터 없음 | |
Additional Non-Executive & Independent Director | 4.4yrs | ₹285.00k | 데이터 없음 | |
Additional Independent Non-Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
Additional Non Executive Independent & Woman Director | 4.4yrs | ₹245.00k | 데이터 없음 | |
Additional Non Executive & Independent Director | 4.4yrs | ₹260.00k | 데이터 없음 | |
Additional Non-Executive & Non-Independent Director | 1.1yrs | ₹100.00k | 데이터 없음 |
4.4yrs
평균 재임 기간
48yo
평균 연령
경험이 풍부한 이사회: ORCHPHARMA's board of directors are considered experienced (4.4 years average tenure).